Predicted protein targets (top 13)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | MEN1 | O00255 | 1/20 | 0.56 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.56 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.35 |
| ▸ | TDP1 | Q9NUW8 | 1/20 | 0.35 |
| ▸ | MMP9 | P14780 | 1/20 | 0.35 |
| ▸ | MMP13 | P45452 | 1/20 | 0.35 |
| ▸ | NR1H2 | P55055 | 1/20 | 0.32 |
| ▸ | NR1H3 | Q13133 | 1/20 | 0.32 |
| ▸ | EGFR | P00533 | 1/20 | 0.32 |
| ▸ | PDE4A | P27815 | 1/20 | 0.30 |
| ▸ | PDE4B | Q07343 | 1/20 | 0.30 |
| ▸ | PDE4C | Q08493 | 1/20 | 0.30 |
| ▸ | PDE4D | Q08499 | 1/20 | 0.30 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL8764230 | 0.86 | MEN1 (0.64) | MEN1KMT2AALDH1A1TDP1MMP9 | |
| SCHEMBL267286 | 0.85 | MEN1 (0.41) | MEN1KMT2AALDH1A1TDP1 | |
| SCHEMBL27484461 | 0.83 | MEN1 (0.40) | MEN1KMT2A | |
| SCHEMBL6576818 | 0.80 | GFER (0.40) | MEN1KMT2AALDH1A1TDP1 | |
| Benzene SCHEMBL28469748 | 0.79 | MEN1 (0.70) | MEN1KMT2AALDH1A1TDP1NR1H2 | |
| SCHEMBL8763175 | 0.79 | MEN1 (0.56) | MEN1KMT2AALDH1A1TDP1MMP9 | |
| SCHEMBL9552869 | 0.79 | KMT2A (0.56) | MEN1KMT2AALDH1A1TDP1MMP9 | |
| SCHEMBL13618845 | 0.79 | MEN1 (0.70) | MEN1KMT2AALDH1A1TDP1NR1H2 | |
| SCHEMBL181108 | 0.79 | MEN1 (0.70) | MEN1KMT2AALDH1A1TDP1NR1H2 | |
| SCHEMBL5702908 | 0.77 | MEN1 (0.33) | MEN1KMT2AALDH1A1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 251 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-112778125-B | Aryl phenol compound and synthesis method and application thereof | 华东师范大学 | 2023-02-17 | — | — | CN | claimed |
| CN-112778125-A | Aryl phenol compound and synthesis method and application thereof | 华东师范大学 | 2021-05-11 | — | — | CN | claimed |
| WO-2013055910-A1 | MODULATORS OF THE GPR119 RECEPTOR AND THE TREATMENT OF DISORDERS RELATED THERETO | ARENA PHARMACEUTICALS, INC. (US) | 2013-04-18 | — | — | WO | claimed |
| US-8231941-B2 | Procedure for preparing redox-active polymers on surfaces | THE REGENTS OF THE UNIVERSITY OF CALIFORNIA (US) | 2012-07-31 | — | — | US | claimed |
| US-20100330284-A1 | PROCEDURE FOR PREPARING REDOX-ACTIVE POLYMERS ON SURFACES | THE REGENTS OF THE UNIVERSITY OF CALIFORNIA (US) | 2010-12-30 | — | — | US | claimed |
| CN-100577410-C | Method for preparing redox-active polymers on surfaces | UNIV CALIFORNIA | 2010-01-06 | — | — | CN | claimed |
| EP-1620885-B1 | ORGANIC POLYMERS, ELECTRONIC DEVICES, AND METHODS | 3M INNOVATIVE PROPERTIES CO (US) | 2009-08-12 | — | — | EP | claimed |
| EP-1635821-B1 | 4-BROMO-5-(2-CHLORO-BENZOYLAMINO)-1H-PYRAZOLE-3-CARBOXYLIC ACID (PHENYL)AMIDE DERIVATIVES AND RELATED COMPOUNDS AS BRADYKININ B1 RECEPTOR ANTAGONISTS FOR THE TREATMENT OF INFLAMMATORY DISEASES | ELAN PHARM INC (US) | 2009-07-08 | — | — | EP | claimed |
| US-7473652-B2 | Organic polymers, electronic devices, and methods | 3M INNOVATIVE PROPERTIES COMPANY (US) | 2009-01-06 | — | — | US | claimed |
| US-7452572-B1 | Procedure for preparing redox-active polymers on surfaces | THE NORTH CAROLINA STATE UNIVERSITY (US) | 2008-11-18 | — | — | US | claimed |
| WO-2005017953-A2 | IN SITU PATTERNING OF ELECTROLYTE FOR MOLECULAR INFORMATION STORAGE DEVICES | THE REGENTS OF THE UNIVERSITY OF CALIFORNIA (US) | 2005-02-24 | — | — | WO | claimed |
| US-20050032868-A1 | Selected substituted pyrazole derivatives and related compounds as bradykinin B1 receptor antagonists | ELAN PHARMACEUTICALS, INC. | 2005-02-10 | — | — | US | claimed |
| US-20050019592-A1 | Organic polymers, laminates, and capacitors | 3M INNOVATIVE PROPERTIES COMPANY | 2005-01-27 | — | — | US | claimed |
| WO-2004102690-A2 | ORGANIC POLYMERS, LAMINATES, AND CAPACITORS | 3M INNOVATIVE PROPERTIES COMPANY (US) | 2004-11-25 | — | — | WO | claimed |
| WO-2004102652-A1 | ORGANIC POLYMERS, ELECTRONIC DEVICES, AND METHODS | 3M INNOVATIVE PROPERTIES COMPANY (US) | 2004-11-25 | — | — | WO | claimed |
| WO-2004099155-A2 | 4-BROMO-5-(2-CHLORO-BENZOYLAMINO)-1H-PYRAZOLE-3-CARBOXYLIC ACID (PHENYL) AMIDE DERIVATES AND RELATED COMPOUNDS AS BRADYKININ B1 RECEPTOR ANTAGONISTS FOR THE TREATMENT OF INFLAMATORY DISEASES | ELAN PHARMACEUTICALS, INC. (US) | 2004-11-18 | — | — | WO | claimed |
| US-20040222412-A1 | Organic polymers, electronic devices, and methods | 3M INNOVATIVE PROPERTIES COMPANY | 2004-11-11 | — | — | US | claimed |
| US-20040120180-A1 | Variable-persistence molecular memory devices and methods of operation thereof | NORTH CAROLINA STATE UNIVERSITY | 2004-06-24 | — | — | US | claimed |
| WO-2003102153-A2 | CELL MIGRATION INHIBITING COMPOSITIONS AND METHODS AND COMPOSITIONS FOR TREATING CANCER | AVOLIX PHARMACEUTICALS (US) | 2003-12-11 | — | — | WO | claimed |
| US-4275184-A | HYDROSILATION OF POLYDIMETHYL SILOXANE | RHONE-POULENC INDUSTRIES (FR) | 1981-06-23 | — | — | US | claimed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20050032868-A1 | Selected substituted pyrazole derivatives and related compounds as bradykinin B1 receptor antagonists | BDKRB1, BDKRB2, BRS3 | MEN1 1180/4885KMT2A 4030/4885ALDH1A1 3108/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.